Neukio Biotherapeutics

Developer of cell therapies to treat cancer

placeShanghai, Shanghai, China calendar_todayFounded 2021 language neukio.com

Innovation

5 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 44 times.

YearFilings
20231
20244
20252
20261

Investor mix

7 investors on record; lead investors include CD Capital Asset Management.

Investor typeCountShare
Venture capital229%
Private equity114%
Other / undisclosed457%
Coming soon